Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Retained Earnings (2017 - 2025)

Entera Bio has reported Retained Earnings over the past 9 years, most recently at $41000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings changed 0.0% year-over-year to $41000.0, compared with a TTM value of $41000.0 through Dec 2025, changed 0.0%, and an annual FY2025 reading of $41000.0, changed 0.0% over the prior year.
  • Retained Earnings came in at $41000.0 for Q4 2025, roughly flat from $41000.0 in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $41000.0 in Q2 2022 to a low of -$116.5 million in Q1 2025.
  • Median Retained Earnings over the past 5 years was -$82.4 million (2021), compared with a mean of -$52.4 million.
  • The sharpest move saw Retained Earnings surged 100.05% in 2023, then crashed 259619.51% in 2024.
  • Over 5 years, Retained Earnings stood at -$82.4 million in 2021, then fell by 15.86% to -$95.5 million in 2022, then skyrocketed by 100.04% to $41000.0 in 2023, then changed by 0.0% to $41000.0 in 2024, then changed by 0.0% to $41000.0 in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Retained Earnings are $41000.0 (Q4 2025), $41000.0 (Q3 2025), and $41000.0 (Q2 2025).